Ponesimod Compared With Teriflunomide in Patients With Relapsing Multiple Sclerosis in the Active-Comparator Phase 3 OPTIMUM Study: A Randomized Clinical Trial - Kappos, L; Fox, RJ; Burcklen, M (JAMA Neurol, 2021)
et al.